{"transactions":[{"id":766338,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":298194,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."}],"balance_after":298194,"derivative":{"exercise_price":6.58,"underlying":"Ordinary Shares","underlying_shares":298194},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766337,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":298195,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."}],"balance_after":298195,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":298195},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766336,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":95575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":95575},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766335,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":95575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The RSUs vested on 05/21/2026 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vested on 05/21/2026 and had no expiration date."}],"balance_after":95575,"derivative":{"exercise_price":0,"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":95575},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766334,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":92746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":92746},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766333,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":92746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The RSUs vested on 05/21/2026 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vested on 05/21/2026 and had no expiration date."}],"balance_after":92746,"derivative":{"exercise_price":0,"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":92746},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766332,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":103364,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant."}],"balance_after":103364,"derivative":{"exercise_price":8.12,"underlying":"Ordinary Shares","underlying_shares":103364},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766331,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Options","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":214988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."}],"balance_after":214988,"derivative":{"exercise_price":6.58,"underlying":"Ordinary Shares","underlying_shares":214988},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766330,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":214999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."}],"balance_after":214999,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":214999},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766329,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":103365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit (the \"RSUs\") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit (the \"RSUs\") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit (the \"RSUs\") represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date."}],"balance_after":103365,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":103365},"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766328,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":95575,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote (2)"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":1193569,"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766327,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44805,"kind":"person","name":"Zhai Yifan","position":1,"cik":"0002123017","reported_name":"Zhai Yifan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:44:39.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":92746,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":405280,"source":{"system":"sec-edgar","filing":"0001213900-26-060632","document":"marketforms-73254.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060632/marketforms-73254.xml","form_type":"4"}},{"id":766326,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":92746,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person's spouse on 05/20/2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":92746},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766325,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":92746,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"The RSUs vested on 05/21/2026 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"The RSUs vested on 05/21/2026 and had no expiration date."}],"balance_after":92746,"derivative":{"exercise_price":0,"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":92746},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766324,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Options","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":103364,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and expire ten years from the date of grant."}],"balance_after":103364,"derivative":{"exercise_price":8.12,"underlying":"Ordinary Shares","underlying_shares":103364},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766323,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Options","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":214988,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."}],"balance_after":214988,"derivative":{"exercise_price":6.58,"underlying":"Ordinary Shares","underlying_shares":214988},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766322,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":214999,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."}],"balance_after":214999,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":214999},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766321,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":103365,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The RSUs vest in four equal increments on November 26, 2026, 2027, 2028 and 2029 and have no expiration date."}],"balance_after":103365,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":103365},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766320,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Options","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":298194,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The exercise price of the options is in HKD and the exercise price included in the table represents conversion to USD based on the exchange rate as of the date of grant. The options vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and expire ten years from the date of grant."}],"balance_after":298194,"derivative":{"exercise_price":6.58,"underlying":"Ordinary Shares","underlying_shares":298194},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766319,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":298195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs vest in four equal increments on May 21, 2027, 2028, 2029 and 2030 and have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":298195},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766318,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":false,"shares":95575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Represents the vesting in full on 5/21/2026 of the RSUs granted to the Reporting Person on 05/20/2026."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Ordinary Shares","underlying_shares":95575},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766317,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Restricted stock units","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":95575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each restricted stock unit (the \"RSUs\") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit (the \"RSUs\") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Each restricted stock unit (the \"RSUs\") represent a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vested on 05/21/2026 and had no expiration date."}],"balance_after":95575,"derivative":{"exercise_price":0,"exercise_date":"2026-05-21","underlying":"Ordinary Shares","underlying_shares":95575},"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766316,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":92746,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote (2)"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes."}],"balance_after":405280,"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":766315,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":44804,"kind":"person","name":"Yang Dajun","position":1,"cik":"0002059751","reported_name":"Yang Dajun","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Ordinary Shares","published_at":"2026-05-22T20:18:28.000Z","date":"2026-05-21","kind":"exercise","planned":false,"acquired":true,"shares":95575,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1193569,"source":{"system":"sec-edgar","filing":"0001213900-26-060585","document":"marketforms-73253.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026060585/marketforms-73253.xml","form_type":"4"}},{"id":803832,"issuer":{"id":4672,"kind":"organization","name":"ASCENTAGE PHARMA GROUP INTERNATIONAL"},"owners":[{"id":51813,"kind":"person","name":"Misra Veet","position":1,"cik":"0002122967","reported_name":"Misra Veet","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted stock units","published_at":"2026-04-21T17:37:44.000Z","date":"2026-04-20","kind":"grant","planned":false,"acquired":true,"shares":18584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest immediately and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest immediately and have no expiration date."}],"balance_after":18584,"derivative":{"exercise_price":0,"underlying":"Restricted stock units","underlying_shares":18584},"source":{"system":"sec-edgar","filing":"0001213900-26-046036","document":"marketforms-72968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2023311/000121390026046036/marketforms-72968.xml","form_type":"4"}}]}